Optimization of nutrition: Polyphenols and vascular protection

Nutrition Reviews

Volumn 57, Issue 8, 1999, Pages 241-249

  Ursini, Fulvio ^a   Tubaro, Franco ^b   Rong, James ^c   Sevanian, Alex ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXIDE; PHOSPHOLIPID; POLYPHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOLOGY; DIETARY INTAKE; KINETICS; MALE; NONHUMAN; NUTRITION; OXIDATION REDUCTION REACTION; PATHOLOGY; RAT; THERMODYNAMICS;

ANIMALIA;

EID: 0032823430     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1999.tb06951.x     Document Type: Article

References (83)

1. National Research Council. Recommended Dietary Allowances, 10th edition. Washington, DC: National Academy Press, 1989
2. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56:317-33
3. Riemersma RA, Wood DA, Macintyre CCH, et al. Risk of angina pectoris and plasma concentration of vitamins A, C, and E and carotene. Lancet 1991;337:1-5
4. Stampfer ML, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9
5. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol 1997;26:1-13
6. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16
7. Jialal I, Grundy SM. Effect of supplementation with alpha tocopherol, ascorbate and beta-carotene on low density lipoprotein oxidation. Circulation 1993;88:2780-6
8. Hertog M, Feskens E, Hollman P, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993;342:1007-11
9. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect. Proc Natl Acad Sci U S A 1987;84:7725-9
10. Williams RJ, Motteram JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992;94:153-9
11. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996;20:707-27
12. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-24
13. Harada-Shiba M, Kinoshita M, Kamido H, Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem 1998;273:9681-7
14. Boissonneault GA, Wang Y, Chung BH. Oxidized low-density lipoproteins delay endothelial wound healing: lack of effect of vitamin E. Ann Nutr Metab 1995;39:1-8
15. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995;270:319-24
16. Maor I, Aviram M. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester. J Lipid Res 1994;35:803-19
17. Hajjar DP, Pomerantz KB. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J 1992;6:2933-41
18. - is a lipid hydroperoxide-enriched circulating lipoprotein. J Lipid Res 1997;38:419-28
19. Sevanian A, Hwang J, Hodis HN, et al. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler Thromb Vasc Biol 1996;16:784-93
20. Rifici VA, Khachadurian AK. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim Biophys Acta 1996;1299:87-94
21. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 1993;125:958-73
22. Yamaguchi Y, Kitagawa S, Imaizumi N, et al. Enhancement of aortic cholesterol deposition by dietary linoleic acid in cholesterol-fed mice: an animal model for primary screening of antiatherosclerotic agents. J Pharmacol Toxicol Methods 1993;30:169-75
23. Erdincler DS, Seven A, Inci F, et al. Lipid peroxidation and antioxidant status in experimental animals: effects of aging and hypercholesterolemic diet. Clin Chim Acta 1997;265:77-84
24. Hodis HN, Chauhan A, Hashimoto S, et al. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. Atherosclerosis 1992;96:125-34
25. Renaud S, de Logeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992;339:1523-6
26. Frankel EN, Kanner J, German JB, et al. Inhibition of oxidation of human low density lipoprotein by phenolic substances in wine. Lancet 1993;341: 454-7
27. Kondo K, Matsumoto A, Kurata H, et al. Inhibition of oxidation of human low density lipoprotein with red wine. Lancet 1994;344:1152
28. Aviram M, Hayek T, Fuhrman B. Red wine consumption inhibits LDL oxidation and aggregation in humans and in atherosclerotic mice. Biofactors 1997;6:415-9
29. Folts JD, Bergolli B, Shanmuganayagam D, et al. Inhibition of platelet activity with red wine and grape products. Biofactors 1997;6:411-4
30. Fitzpatrick D, Maggi D, Bing B, Coffey R. Vasorelaxation, endothelium and wine. Biofactors 1997;6: 455-9
31. Teissedre PL, Frankel EN, Waterhouse AL, et al. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J Sci Food Agric 1996;70:55-61
32. Kurfeld MD, Kritchevsky D. Differential effect of alcoholic beverages on experimental atherosclerosis in rabbits. Exp Mol Pathol 1981;34:62-71
33. Yugarani T, Tan BKII, Das NP. Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 1992;27:181-6
34. Tebib K, Bitri I, Rouanet JM. Polymeric grape seed tannins prevent plasma cholesterol changes in high cholesterol fed rats. Food Chem Toxicol 1994;49: 403-6
35. Ruf JC, Berger JL, Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Arterioscler Thromb Vasc Biol 1995;15:140-4.
36. Yamaloshi J, Kataoka S, Koga T, Ariga T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999;142:139-49
37. Salunkhe DK, Chavan JK, Kadam SS. Dietary tannins: consequences and remedies. Boca Raton: CRC Press, 1990
38. Foo LY, Porter LJ. The structure of tannins of some edible fruits. J Sci Food Agric 1981;32:711-6
39. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-8
40. Shaw IC, Griffiths LA. Identification of the major biliary metabolite of (+)-catechin in the rat. Xenobiotica 1980;10:905-11
41. Unno T, Takeo T. Absorption of (-)-epigallocatechin gallate into the circulation system of rats. Biosci Biotech Biochem 1995;59:1558-9
42. Hollman PCH, de Vries JHM, van Leeuwen SD, et al. Absorption of dietary quercetin glucosides in healthy ileostomy volunteers. Am J Clin Nutr 1995;62:1276-82
43. Hollman PCH, van de Gaag M, Mengelers MJB, et al. Absorption and disposition kinetics of the dietary antioxidant quercitin in man. Free Radic Biol Med 1996;21:703-7
44. Paganga G, Rice-Evans CA. The identification of flavonoids as glycosides in human plasma. FEBS Lett 1997;401:78-82
45. Unno T, Kondo K, Itsukura H, Takeo T. Analysis of (-)-epigallocatechingallate in human serum obtained after ingestion of tea. Biosci Biotech Biochem 1996;60:2066-8
46. Jimenez-Ramsye LM, Rogler JC, Housley TL, et al. Absorption and distribution of 14C-labeled condensed tannins and related Sorghum phenolics in chickens. J Agric Food Chem 1994;42:963-7
47. Serafini M, Ghiselli A, Ferro-Luzzi A. Red wine, tea and antioxidants. Lancet 1994;344;626
48. Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 1996;50:28-32
49. Tubaro F, Ghiselli A, Rapuzzi P, et al. Analysis of plasma antioxidant capacity by competition kinetics. Free Radic Biol Med 1998;24:1228-34
50. Ishikawa T, Suzukawa M, Ito T, et al. Effect of tea flavonoid supplementation on susceptibility of low density lipoprotein to oxidative modification. Am J Clin Nutr 1997;66:261-6
51. van Acker SABE, van den Berg D, Tromp MNJL, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996;20:331-42
52. Arora A, Nair MG, Strasburg GM. Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med 1998;24:1355-63
53. Born M, Carrupt P, Zini R, et al. Electrochemical behaviour and antioxidant activity of some natural polyphenols. Helvetica Chimica Acta 1996;79: 1147-58
54. von Sonntag C, Schuchmann H. Pulse radiolysis. Methods Enzymol 1994;233:3-20
55. Forni LG, Willson RL. Electron and hydrogen atom transfer reactions: determination of free radical redox potentials by pulse radiolysis. Methods Enzymol 1984;105:179-88
56. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 1990;186:343-55
57. Jovanovic SV, Steenke S, Tosic M, et al. Flavonoids as antioxidants. J Am Chem Soc 1994;116:4846-51
58. Bors W, Michel C, Schikora S. Interaction of flavonoids with ascorbate and determination of their univalent redox potentials: a pulse radiolysis study. Free Radic Biol Med 1995;19:45-52
59. Steenken S. One-electron redox potentials of phenols. Hydroxy-and aminophenols and related compounds of biological interest. J Phys Chem 1982;86:3661-7
60. Hodnick WF, Milosavijevic EB, Nelson JH, Pardini RS. Electrochemistry of flavonoids. Relationships between redox potentials, inhibition of mitochondrial respiration, and production of oxygen radicals by flavonoids. Biochem Pharmacol 1988;37:2607-11
61. Rapta P, Misik V, Stasko A, Vrabel I. Redox intermediates of flavonoids and caffeic acid esters from propolis: an epr spectroscopy and cyclic voltametry study. Free Radic Biol Med 1995;18:901-8
62. Afanas'ev IB, Dorozhko Al, Brodskii AV, et al. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercitin in lipid peroxidation. Biochem Pharmacol 1989;38:1763-9
63. Morel I, Lescoat G, Cogrel P, et al. Antioxidant and iron-chelating activities of the flavonoids catechin, quercitin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol 1993;45:13-9
64. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56
65. 4-induced microsomial lipid peroxidation. Experientia 1991;47:195-9
66. Ratty AK, Das NP. Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Oncology 1988;39:69-79
67. Hagerman AE, Riedl KM, Jones AG, et al. High molecular weight plant polyphenolics (tannins) as biological antioxidants. J Agr Food Chem 1998;46:1887-92
68. Ariga T, Hamano M. Radical scavenging action and its mode in procyanidins B1 and B3 from Azuki beans to peroxyl radicals. Agric Chem Biol 1990;54:2499-504
69. Nuttal SL, Kendall MJ, Bombardelli E, Morazzoni P. A clinical evaluation of the antioxidant activity of a bioavailable standardized grape seed extract (Leucoselect™-Phytosome®). J Clin Pharm Ther (in press)
70. Jokinen MP, Clarkson TB, Prichard RW. Recent advances in molecular pathology. Animal models in atherosclerosis research. Exp Mol Pathol 1985;42:1-28
71. Evan AS, Myers GL. Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 2nd ed. Philadelphia, PA: W.B. Saunders Company, 1994;1002-93
72. Holvoet P, Collen D. VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997;17:2376-82
73. Bocan TMA, Mueller SB, Mazur MJ, et al. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis 1993;102:9-22
74. Kolodgie FD, Katocs AS, Largis EE, et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Arterioscler Thromb Vasc Biol 1996;16:1454-64
75. Pastorino AM, Zamburlini A, Zennaro L, et al. Measurement of lipid hydroperoxides in human plasmamand lipoproteins by kinetic analysis of photon emission. Methods Enzymol 1998;300:33-43
76. Rong JX, Rangaswamy S, Shen L, et al. Vascular injury by cholesterol oxidation products in an animal model of atherosclerosis. Arterioscler Thromb Vase Biol 1998;18:1885-94
77. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983;52:223-61
78. Gelissen IC, Brown AJ, Mander EL, et al. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem 1996;271:17852-60
79. Krithraides L, Jessup W, Mander EL, Dean RT. Apolipoprotein A-1-mediated efflux from oxidized LDL-loaded macrophages. Arterioscler Thromb Vase Biol 1995;15:276-89
80. Li W, Yuan XM, Olsson AG, Brunk UT. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler Thromb Vasc Biol 1998;18:177-8
81. Hoff HF, Hoppe G. Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation. Curr Opin Lipidol 1995;6:317-25
82. Ursini F, Zamburlini A, Cazzolato G, et al. Postprandial plasma hydroperoxides: a possible link between diet and atherosclerosis. Free Radic Biol Med 1998;25:250-2
83. Staprans I, Rapp JH, Pan XM, Feingold KR. Oxidized lipids in the diet are incorporated by the liver into very low density lipoprotein in rats. J Lipid Res 1996;37:420-30